Oncology: Penile/Testis

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Augue lacus viverra vitae congue. Consequat mauris nunc congue nisi vitae. Ut consequat semper viverra nam. Vulputate eu scelerisque felis imperdiet.

This set of activities will focus on penile and testicular cancer. 

Target Audience

  • Advanced practice providers

Learning Objectives

After participating in this activity, the learner will be able to:

Testis Cancer:

  1. Define the evaluation of a newly diagnosed testis mass and the role of serum markers like AFP and b-hcg as well as the importance of cross-sectional imaging.
  2. Describe the staging of testis cancer.
  3. Describe the primary treatment options for patients with stage I testis cancer including the role of surgery, radiation therapy, chemotherapy, and active surveillance.
  4. Describe the primary treatment options for patients with stage II and III testis cancer including the role of surgery, radiation therapy, and chemotherapy.
  5. Describe algorithms for the active surveillance of stage I testis cancer.
  6. Define the time points and diagnostic tests for cancer surveillance of patients treated for stages I-II testis cancer.

Penile Cancer:

  1. Define the evaluation of a newly diagnosed penile mass.
  2. Describe the staging of penile cancer.
  3. Describe the role of inguinal lymphadenectomy for patients with clinically localized penile cancer.
  4. Define the time points and diagnostic tests for cancer surveillance of patients treated for clinically localized penile cancer.
Course summary
Course opens: 
02/20/2019
Course expires: 
02/20/2022
Parent activity set: 
Rating: 
0

NOTE: This activity is a non-CME resource. CME is not awarded for this activity. 

Available Credit

Accreditation Period

Course opens: 
02/20/2019
Course expires: 
02/20/2022
Please login or register to take this course.

To continue with this activity, please click on the TAKE COURSE button above.